which glp-1 agonists have cardiovascular benefit benefits of glucagon-like peptide-1 receptor Can one drug do it

JAMA Netw Open 2024;7:e2413172

The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited

In this review, we showed that GLP-1 receptor agonists can effectively change cognitive function, BMI and blood glucose levels in patients with AD

Leave a Comment Related Blogs Explore By Categories What's holding you back from reaching your health goals

Researchers from the German Center for Diabetes Research (DZD) and Helmholtz Munich, in collaboration with a colleague from the University of Santiago de Compostela in Spain, describe the development of incretin-based pharmacotherapy from its beginnings to the discovery of polyagonists